| Dr Elizabeth Bryniarski, MD | |
|
1100 Central Ave Se, 4th Floor B, Albuquerque, NM 87106-4930 | |
| (505) 724-6124 | |
| (505) 724-6125 |
| Full Name | Dr Elizabeth Bryniarski |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 33 Years |
| Location | 1100 Central Ave Se, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326133067 | NPI | - | NPPES |
| 200410970A | Medicaid | OK | |
| 28513 | Other | NE | LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Researchers from Spain have identified several new splicing events regulated by the oncogenic splicing factor SRSF1 in lung cancer, suggesting that their dysregulation is involved in the pathogenesis of the disease.
New Johns Hopkins research showing a more than four-fold increase in the incidence of breast cancer in women with neurofibromatosis-1 (NF1) adds to growing evidence that women with this rare genetic disorder may benefit from early breast cancer screening with mammograms beginning at age 40, and manual breast exams as early as adolescence.
A naturally occurring molecule in the body appears to control whether certain medications, such as beta adrenergic receptor agonists used in acute heart failure or in inhalers for asthma, lose their effectiveness over time.
› Verified 7 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Researchers from Spain have identified several new splicing events regulated by the oncogenic splicing factor SRSF1 in lung cancer, suggesting that their dysregulation is involved in the pathogenesis of the disease.
New Johns Hopkins research showing a more than four-fold increase in the incidence of breast cancer in women with neurofibromatosis-1 (NF1) adds to growing evidence that women with this rare genetic disorder may benefit from early breast cancer screening with mammograms beginning at age 40, and manual breast exams as early as adolescence.
A naturally occurring molecule in the body appears to control whether certain medications, such as beta adrenergic receptor agonists used in acute heart failure or in inhalers for asthma, lose their effectiveness over time.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Bryniarski, MD Po Box 26666, Phs Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-6770 | Dr Elizabeth Bryniarski, MD 1100 Central Ave Se, 4th Floor B, Albuquerque, NM 87106-4930 Ph: (505) 724-6124 |
News Archive
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Researchers from Spain have identified several new splicing events regulated by the oncogenic splicing factor SRSF1 in lung cancer, suggesting that their dysregulation is involved in the pathogenesis of the disease.
New Johns Hopkins research showing a more than four-fold increase in the incidence of breast cancer in women with neurofibromatosis-1 (NF1) adds to growing evidence that women with this rare genetic disorder may benefit from early breast cancer screening with mammograms beginning at age 40, and manual breast exams as early as adolescence.
A naturally occurring molecule in the body appears to control whether certain medications, such as beta adrenergic receptor agonists used in acute heart failure or in inhalers for asthma, lose their effectiveness over time.
› Verified 7 days ago
Melissa A Merhege, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne Ste 213, Albuquerque, NM 87102 Phone: 505-727-7177 Fax: 505-727-3778 | |
Dr. Anju C Jaiswal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Children Psychiatric Hospital, 1001 Yale Blvd., Albuquerque, NM 87131 Phone: 505-272-2890 | |
George Edwin Davis, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1002 Idlewilde Ln Se, Albuquerque, NM 87108 Phone: 505-270-7479 | |
Shannon Stromberg, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Unm Psychiatric Ctr, 2600 Marble Ne, Albuquerque, NM 87131 Phone: 505-272-2800 Fax: 505-272-8692 | |
Liz-beth Porter, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unm Hospital Psychiatry, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Mr. Ronald Lee Romanik, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7520 Montgomery Blvd Ne, Suite D12, Albuquerque, NM 87109 Phone: 505-323-6969 Fax: 505-323-9696 | |
Dr. Justin F Beatty, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Msc 09 5030 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-2223 |